Abstract Details
|
Sagari R. Bette, MD
(Parkinson's Disease and Movement Disorders Center of Boca Raton)
PRESENTER |
Dr. Bette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. Dr. Bette has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa Kirin. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bette has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merz. Dr. Bette has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. |
| Jason H. Margolesky, MD, FAAN (University of Miami School of Medicine) | Dr. Margolesky has nothing to disclose. |
| Corneliu C. Luca, MD (University of Miami) | Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. |
| Henry P. Moore, MD (University of Miami - Miller School of Medicine) | Dr. Moore has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Moore has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen Pharma. The institution of Dr. Moore has received research support from Sage Therapeutics. The institution of Dr. Moore has received research support from Bukwang Pharmaceutical. The institution of Dr. Moore has received research support from Neurocrine. The institution of Dr. Moore has received research support from CDHI Foundation. The institution of Dr. Moore has received research support from MODUS Outcomes LLC. The institution of Dr. Moore has received research support from University of Kansas Center for Research. |
| Carlos Singer, MD (University of Miami) | Dr. Singer has nothing to disclose. |
| Yolanda Reyes-Iglesias, MD, FAAN (University of Miami) | Dr. Reyes-Iglesias has received personal compensation in the range of $500-$4,999 for serving as a Member Neuroscience Test Development Material Committee with National Board medical examiners (NBME). Dr. Reyes-Iglesias has received personal compensation in the range of $500-$4,999 for serving as a Lecturer with Harvard Prime Med Series. |